Magic mushroom compound takes on opioid crisis in new trial
Disease control
Recruiting now
This study tests whether a single dose of psilocybin (the active ingredient in magic mushrooms) can help people with opioid use disorder who are already on medication. 36 participants will receive either a high or low dose and be followed for a year. The goal is to see if psilocy…
Phase: PHASE2 • Sponsor: Anna Rose Childress, Ph.D. • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC